Best GLP-1 Cash Pay Programs (2026)

By WPG Research Team · Last verified: April 8, 2026

Independent comparison. Some links are affiliate links. See disclosure. We include non-affiliate programs (NovoCare, LillyDirect, GoodRx, Mochi) where they fit the data.

Real month-one and refill pricing for people paying out of pocket. The best GLP-1 cash pay programs depend on which lane you want — and the real price after month one, not the ad price. We verified pricing, membership fees, refill costs, and cancellation terms across every major cash-pay option available right now.

Quick picks by lane:

Best brand-name self-pay value: GoodRx Care Direct$39/mo membership + Wegovy pill from $149/mo · FDA-approved only
Lowest compounded semaglutide (month-to-month): Mochi Health$178/mo all-in ($79 membership + $99 medication at all doses)
Best no-membership compounded option: EdenCompounded semaglutide from $129/mo first month (3-month plan) · No platform fee
Best FDA-approved daily pill (manufacturer-direct): LillyDirect Foundayo$149–$299/mo depending on dose · No membership fee · Orforglipron
If your insurance already covers Wegovy or Zepbound at a reasonable copay, a cash-pay program is usually not your best path. Check coverage first — even a $50 copay beats most cash-pay pricing. For everyone else, keep reading.
Best GLP-1 Cash-Pay Programs — The best option depends on your lane. GoodRx Care Direct: best brand-name self-pay value, $39/month membership, brand-name options from $149, FDA-approved only. LillyDirect Foundayo: best FDA-approved daily pill, from $149, no membership fee, higher doses from $299. Mochi Health: lowest month-to-month compounded semaglutide, $79 membership plus $99 medication, $178/month all-in, same medication price at all doses. Eden: best no-membership compounded option, semaglutide from $129 first month, no membership fee, 3-month and monthly plan options.

What Are the Best GLP-1 Cash Pay Programs Right Now?

The market split into three distinct lanes in 2025–2026, and most comparison pages still only show you one of them. Knowing your lane is the single most important decision. Everything else — pricing, cancellation, side-effect support — flows from it.

1

Brand-Name Telehealth

FDA-approved Wegovy or Zepbound through a telehealth platform that adds a membership fee on top of medication cost.

GoodRx Care Direct, Ro, Hims & Hers

Costs more. FDA-approved. May include membership.

2

Manufacturer-Direct

FDA-approved medication through the drug maker's own program — no membership fee. You supply your own prescription.

NovoCare (Wegovy), LillyDirect (Zepbound, Foundayo)

Cleaner monthly math. Less platform overhead.

3

Compounded Telehealth

Compounded semaglutide or tirzepatide from a compounding pharmacy — not FDA-approved as finished products.

Mochi, Eden, MEDVi

Lower cost. Regulatory tradeoffs. Not FDA-approved.

What Do These Programs Really Cost After the Teaser Price Ends?

Most GLP-1 cash-pay programs advertise a first-month price that does not reflect what you will actually pay at a maintenance dose. The table below normalizes entry price, refill price, membership fees, and our Membership Drag metric across all 7 programs we verified.

ProgramLaneEntry PriceRefill / StandardMembershipMembership DragBest For
GoodRx Care DirectBrand-name telehealthWegovy pill $149/mo; pen $199/mo (first 2 fills)Wegovy pen $349/mo; pill 9mg+ $299/mo$39/mo10.1%FDA-approved self-pay, 70,000+ pharmacies
LillyDirect FoundayoManufacturer-direct pill$149/mo (0.8mg)$199 (2.5mg); $299 (5.5–17.2mg)$00%FDA-approved daily pill, no membership
NovoCare (Wegovy)Manufacturer-directPill $149/mo; pen $199/mo (first 2 fills)Pill 9mg+ $299/mo; pen $349/mo$00%Official semaglutide, zero platform fee
Mochi HealthCompounded telehealth$178/mo all-in$178/mo sema; $278/mo tirz (flat at all doses)$79/mo44.4%Lowest compounded with dietitian access
EdenCompounded telehealth$129/mo (3-mo plan)$209/mo (3-mo); $229/mo (monthly)$00%No-membership compounded, brand-name option
RoBrand-name + insurance crossover$45 first monthWegovy pen $349/mo + $145/mo membership$145/mo29.4%Insurance crossover if coverage may change
MEDViCompounded telehealth$179/mo (semaglutide)$299/mo semaglutide$00%Budget compounded, no membership fee

Sources: Provider official websites (GoodRx.com, Lilly.com/lillydirect, NovoCare.com, JoinMochi.com, TryEden.com, Ro.co, GLP.MedVi.org). Verified April 8, 2026.

Intro Price vs Real Ongoing Cost: Some programs stay flat, others jump after the first month or low-dose phase. GoodRx Care Direct: Wegovy pen from $199 first 2 fills then $349. NovoCare: pill 1.5mg and 4mg $149 limited-time, pen $349 standard. LillyDirect Foundayo: 0.8mg $149, 2.5mg $199, then $299+ with 45-day refill rule trap at highest doses. Mochi Health: flat $79 membership plus $99 semaglutide at all doses. Eden: 3-month plan $129 first month then $209, monthly plan $149 then $229. MEDVi: $179 first month then $299. Color codes: green means flat predictable pricing, yellow means normal price increase, red means big jump or refill deadline trap.

What “Membership Drag” Tells You

Membership Drag is the share of your monthly out-of-pocket spend that goes to the platform fee, not to medication. We calculate it as: membership fee ÷ (membership fee + medication cost) × 100, using the refill price — because that is what you pay for 80%+ of your treatment.

Membership Drag comparison chart. Formula: membership fee divided by (membership fee plus medication cost). GoodRx Care Direct: $39 membership, $349 Wegovy pen medication, 10.1% membership drag. Mochi Health: $79 membership, $99 compounded semaglutide, 44.4% membership drag. Manufacturer-direct programs (NovoCare Wegovy, LillyDirect Foundayo): $0 membership, 0% membership drag. Interpretation: lower membership drag means more money goes to the medication. Higher drag can still be worth it if the platform includes support, coaching, or insurance help.

Manufacturer-direct

0%

NovoCare & LillyDirect — no platform fee. 100% of your spend goes to medication.

GoodRx Care Direct

10.1%

$39 on top of $349 Wegovy pen. Lowest drag among subscription platforms.

Ro

29.4%

$145 on top of $349 Wegovy pen. Includes insurance concierge that could eliminate medication cost entirely.

Mochi Health

44.4%

$79 on top of $99 semaglutide. Highest drag — but includes unlimited physician and dietitian video visits.

High-drag platforms can still be worth it if the membership includes coaching, dietitian access, or insurance help.

The bottom line on price comparisons:

Cheapest sticker price is not the same as cheapest program. Always compare month one, month three, and month six — not just the lead promo. Use the intro vs. ongoing chart above to build your real budget before committing.

Should You Choose Brand-Name, Manufacturer-Direct, or Compounded?

The right lane depends on your risk tolerance, budget, and whether you care about FDA approval. Brand-name self-pay costs $149–$499/mo plus a possible membership fee. Manufacturer-direct costs $149–$449/mo with no membership. Compounded costs $129–$299/mo but the medication is not FDA-approved as a finished product.

Which Cash-Pay GLP-1 Lane Fits You? Start here: what matters most to you? Three lanes. Lane 1: FDA-Approved Only — brand-name telehealth or manufacturer-direct. Examples: GoodRx Care Direct, NovoCare Wegovy, LillyDirect Foundayo, Ro. Usually costs more, may include membership fee unless manufacturer-direct. Lane 2: No Membership Fee — manufacturer-direct or no-fee compounded option. Examples: NovoCare Wegovy, LillyDirect Foundayo, Eden. Cleaner monthly math, less platform overhead. Lane 3: Lowest Monthly Cost — compounded telehealth. Examples: Mochi, Eden, MEDVi. Lower cash-pay pricing. Compounded medications are not FDA-approved as finished products. Best fit by preference: Prefer Pills goes to Foundayo or Wegovy pill. Want Predictable Pricing goes to Mochi. Hate Subscriptions goes to NovoCare, LillyDirect, or Eden.

If you want FDA-approved only

Stick with GoodRx Care Direct, Ro, NovoCare, or LillyDirect Foundayo. Every milligram was manufactured by Novo Nordisk or Eli Lilly under FDA oversight. The Wegovy pill (oral semaglutide for weight loss) launched in early 2026 and changed this lane significantly — starter doses at $149/mo through NovoCare or GoodRx brought FDA-approved semaglutide below many compounded prices for the first time.

If you want the lowest monthly cost

Mochi Health's compounded semaglutide at $178/mo all-in (all doses), Eden's compounded semaglutide from $129/mo on a 3-month promo, and MEDVi at $179 first month are the most competitive. Important context: compounded medications are prepared by 503A or 503B compounding pharmacies — not the original manufacturer — and are not FDA-approved as finished products. The FDA has not reviewed them for safety, effectiveness, or manufacturing quality before marketing.

If you want a daily pill instead of injections

LillyDirect Foundayo (orforglipron) is the standout — it's a new molecular entity, not reformulated semaglutide. FDA-approved, manufacturer-direct, no injections, no empty-stomach protocol. NovoCare Wegovy pill (oral semaglutide) is the other strong option at $149–$299/mo. Both are available without a telehealth membership if you have a prescriber.

If you might use insurance later

Ro is the best bridge program. The $145/mo membership is expensive relative to other options, but it includes an insurance concierge service that handles prior authorization paperwork. If your employer changes plans, Ro's team can pivot you from cash-pay to insurance-covered — potentially saving thousands per year. For pure cash-pay buyers who know they'll never use commercial insurance, Ro is the wrong pick.

Check Ro — insurance concierge + brand-name

2026 FDA enforcement context — compounded buyers read this:

In early 2026, the FDA issued warning letters to over 30 telehealth companies for misleading compounded GLP-1 marketing. The letters targeted marketing that implied compounded products were interchangeable with FDA-approved medications. If a provider's website blurs the line between compounded and FDA-approved, that is the kind of language the FDA is actively policing. Verify your provider holds LegitScript certification and names their pharmacy partners before signing up.

Which Program Fits Your Situation?

Not everyone has the same constraints. Here is a quick match by priority.

Budget under $200/month

Mochi Health compounded semaglutide at $178/mo all-in (flat at all doses). NovoCare Wegovy pill at $149/mo (1.5mg and 4mg). LillyDirect Foundayo at $149/mo (0.8mg starting dose). Eden compounded semaglutide at $129/mo entry on a 3-month plan.

The NovoCare and Foundayo prices are for starting doses — price increases as you titrate up. Mochi stays flat at every dose, which is the strongest budgeting advantage.

You hate membership fees

Eden and MEDVi charge $0 in platform fees. NovoCare and LillyDirect are also membership-free since they're manufacturer-direct. If two options are similar on total cost, the one without a separate membership fee is simpler to cancel and cheaper to pause.

You want FDA-approved medication only

GoodRx Care Direct, NovoCare, LillyDirect Foundayo, and Ro. GoodRx explicitly does not offer compounded alternatives — its entire model is FDA-approved only. If FDA approval is non-negotiable for you, GoodRx's positioning makes the decision clean.

You want the newest daily pill option

LillyDirect Foundayo first — orforglipron, a new molecular entity, not reformulated semaglutide. NovoCare Wegovy pill second — oral semaglutide approved for weight loss. The Foundayo 45-day refill rule at doses 14.5mg and above means setting a calendar reminder is non-optional.

You need all-50-state availability

Mochi Health and Eden both publicly state compounded GLP-1 programs are available in all 50 states. GoodRx Care Direct explicitly excludes Alabama and Louisiana. Always confirm your state during intake — availability can change based on compounding pharmacy licensing and state telehealth laws.

Program-by-Program Breakdowns

Honest upsides, real downsides, and who should skip each program — based on verified pricing and terms.

GoodRx Care Direct

Brand-name telehealth · $39/mo membership + from $149 medication

What we like

  • FDA-approved medications only — no compounded products at all
  • Lowest Membership Drag (10.1%) among platforms charging a subscription
  • Pharmacy network covers 70,000+ retail locations nationwide
  • Pricing clearly posted — medication and membership costs are separate

Honest downsides

  • Does not offer coaching, dietitian access, or clinical hand-holding
  • At $349/mo Wegovy pen + $39/mo membership, all-in is $388/mo — higher than compounded
  • Not available in Alabama or Louisiana
Who should skip it: Anyone on a tight budget open to compounded options. Mochi's $178/mo compounded semaglutide is $210/mo cheaper — $2,520/year in savings.

LillyDirect Foundayo

Manufacturer-direct daily pill · From $149/mo · No membership fee

What we like

  • Cleanest manufacturer-direct pill path — no membership fee, no compounding questions
  • New molecular entity (orforglipron) — simpler dosing than oral semaglutide
  • No empty-stomach protocol required (unlike Wegovy pill)
  • All 50 states via prescriber

Honest downsides

  • Requires a separate prescriber — telehealth consultation not bundled
  • At 14.5mg and 17.2mg: if refill is more than 45 days late, price jumps from $299 to $349
  • Not suitable for injections or compounded pricing needs
Who should skip it: Anyone who needs injectable GLP-1, prefers compounded pricing under $200/mo, or doesn't have an existing prescriber relationship.

NovoCare (Wegovy self-pay)

Manufacturer-direct · From $149/mo · No membership fee

What we like

  • Zero platform fee — no telehealth subscription on top of medication
  • Official Novo Nordisk pricing — the benchmark for brand-name semaglutide
  • Free shipping via NovoCare Pharmacy; retail pickup option
  • All 50 states via prescriber

Honest downsides

  • Promo windows change — $199 pen intro expires June 30, 2026; 4mg pill $149 offer expires Aug 31, 2026
  • Does not include telehealth consultation — you need your own prescriber
  • Government insurance beneficiaries (Medicare, Medicaid) excluded from savings offers
Who should skip it: Anyone who needs a telehealth consultation bundled in, or whose prescriber isn't set up to work with NovoCare.

Mochi Health

Compounded telehealth · $178/mo all-in (flat at all doses)

What we like

  • Flat pricing at every dose — $99 for semaglutide whether 0.22mg or 2.67mg weekly
  • Registered dietitian access included — rare at this price point
  • All 50 states for compounded programs
  • Verified transparent pricing between site and actual cost

Honest downsides

  • $79 membership means 44.4% of monthly spend is platform fee, not medication
  • Compounded semaglutide is not FDA-approved as a finished product
  • Ads promote $39 as starting price (first-month membership) — site is more transparent than ads
Who should skip it: Anyone who only wants FDA-approved medication. GoodRx or NovoCare is a cleaner path.

Eden

Best No-Membership Compounded

Compounded telehealth · No membership fee · From $129/mo (3-month plan) · No platform fee

See Eden plans

What we like

  • No separate membership fee — your payment is the medication price
  • Flat pricing at every dose — no price jump as you titrate up
  • Access to brand-name medications (Ozempic, Wegovy, Zepbound, Mounjaro) if needed
  • All 50 states (provider-stated)

Honest downsides

  • $129/mo entry requires a 3-month plan; ongoing rate on that plan is $209/mo
  • Monthly plan ongoing rate is $229/mo — $20/mo more than 3-month plan
  • No refunds once a billing cycle processes
  • Lighter-touch provider oversight than platforms with monthly video visits
Who should skip it: Anyone who wants maximum clinical support with monthly physician and dietitian video visits. Mochi's $79 membership buys substantially more clinical time.

Ro

Brand-name telehealth + insurance crossover · $45 first month → $145/mo membership + medication

Check Ro pricing

What we like

  • Insurance concierge service handles prior authorization paperwork
  • Best bridge program if your coverage situation may change
  • Cash-pay Wegovy and Zepbound available at standard self-pay rates
  • Can pivot you from cash-pay to insurance-covered when coverage comes through

Honest downsides

  • At $145/mo membership + $349/mo Wegovy pen = $494/mo all-in
  • Membership auto-renews and is non-refundable once charged
  • Must cancel at least 48 hours before renewal — strictest policy in this comparison
  • Insurance concierge applies to commercial plans only — not Medicare or Medicaid
Who should skip it: Pure cash-pay buyers who know they'll never use commercial insurance for GLP-1. You'd pay $1,740/year in membership for a service you won't use.

MEDVi

Compounded telehealth · No membership fee · $179 first month → $299/mo ongoing

See MEDVi pricing

What we like

  • No membership fee — $179 first month is genuinely $179, $299 ongoing is genuinely $299
  • 24/7 provider support, month-to-month flexibility, no long-term contracts
  • FDA-approved medication paths also available (Wegovy, Zepbound)
  • ~12,000 Trustpilot reviews · 4.4-star average

Honest downsides

  • 72-hour cancellation notice required before billing date
  • Refills jump from $179 to $299 after month one — a $120 increase
  • FDA warning letter issued February 2026 for marketing claims (not medication safety)
  • Multiple reports of auto-renewal confusion — read cancellation policy carefully
Who should skip it: Anyone who wants a provider with a longer public track record, or prefers FDA-approved medication exclusively. GoodRx is a cleaner pick for brand-name only.

Why Hims & Hers didn't make the core 7

Hims & Hers offers both compounded and brand-name GLP-1 options (Wegovy pill from $149/mo, pen from $199/mo, membership starting at $39 increasing to $149/mo). We excluded Hims from the core comparison because public pricing is harder to normalize cleanly — some pages show uniform dose pricing while fine print indicates pricing may vary by dosage. Hims also does not offer GLP-1s in all 50 states. Hims may still be the right pick for buyers who want brand-name Wegovy through a large, publicly-traded company. See our Hims GLP-1 review →

Which Programs Are Easiest to Cancel — and Where Are the Traps?

Cancellation friction is a real cost that most comparison pages ignore. If you start a program and want to switch after two months, how hard is it to stop paying?

ProgramCancel RuleFriction Level
NovoCare / LillyDirectFill-by-fill. No subscription to cancel.None
GoodRx Care DirectCancel at any timeLow
EdenCancel before next billing date; no refunds once processedLow-medium
MochiCancel before renewal; month-to-monthLow
MEDVi72-hour notice before billing date requiredMedium
Hims & HersCancel anytime, but canceling membership also cancels treatment accessMedium
RoAuto-renewing; cancel 48+ hours before renewal; membership non-refundable once paidHigh

Ro's membership — the strictest cancellation policy in this comparison:

Ro's membership auto-renews and is non-refundable once charged. You must cancel at least 48 hours before your next renewal date. If you miss that window, you're charged for the next cycle with no refund. Manufacturer-direct programs (NovoCare, LillyDirect) win here — there is no subscription to cancel, you simply don't refill.

What Changed in 2026 — and Why Older Pages Are Outdated

Daily pills changed the cash-pay math

Before 2026, cash-pay GLP-1 meant injections. Now the Wegovy pill and LillyDirect Foundayo offer FDA-approved daily oral options at $149–$299/mo. Any comparison page that doesn't include pills is missing the fastest-growing segment of the market.

FDA warning letters changed how you vet compounded sellers

In early 2026, the FDA issued warning letters to over 30 telehealth companies for misleading compounded GLP-1 marketing. On March 3, 2026, the FDA announced the total. The letters targeted marketing that implied compounded products were interchangeable with FDA-approved medications. If a provider's website blurs the line between compounded and FDA-approved, that is a red flag the FDA is actively policing.

Shortage-era assumptions are stale

The semaglutide shortage was resolved in February 2025. The tirzepatide shortage resolved in late 2024/early 2025. The legal basis that allowed broader compounding under the FDA's Drug Shortage List has tightened. Compounded options remain available today, but the regulatory runway is shorter than it was in 2023–2024.

How We Verified This Page

Sources checked (April 8, 2026):

  • GoodRx.com/glp-1-discounts + care/services/glp-1-weight-loss
  • Lilly.com/lillydirect/medicines/foundayo
  • NovoCare.com/pharmacy.html + savings offer page
  • JoinMochi.com + JoinMochi.com/faqs
  • TryEden.com/treatment/glp-1-treatments
  • Ro.co/weight-loss/pricing + Ro.co/terms-of-use
  • GLP.MedVi.org + MEDVi cancellation policy
  • FDA.gov — compounded GLP-1 enforcement announcements
  • Zepbound.lilly.com/savings (self-pay terms)

Methodology notes:

  • Terms-of-service pages used for cancellation rules
  • Trustpilot/Reddit used as secondary trust signals only — not primary price sources
  • Numbers unconfirmable from official pages are marked [NEEDS VERIFICATION]
  • Membership Drag formula: membership fee ÷ (membership fee + refill medication cost) × 100
  • Affiliate status does not affect inclusion — NovoCare, LillyDirect, GoodRx, and Mochi are included at no benefit to us

Update schedule: Monthly re-verify of all prices and promo expiration dates. Last verified: April 8, 2026.

FAQ: GLP-1 Cash Pay Programs

For compounded semaglutide, Mochi Health at $178/mo all-in (all doses) is the lowest verified month-to-month price. For FDA-approved semaglutide, the Wegovy pill through NovoCare at $149/mo (1.5mg and 4mg doses) is the cheapest starting option. For FDA-approved tirzepatide, LillyDirect Zepbound vials at $299/mo (2.5mg starting dose) is the manufacturer-direct benchmark.

Yes. Every program on this page is designed for cash-pay patients. You do not need insurance. You do need a valid prescription from a licensed healthcare provider — most telehealth platforms include the consultation in their service, while manufacturer-direct programs (NovoCare, LillyDirect) require an external prescriber.

Brand-name GLP-1 medications (Wegovy, Zepbound, Foundayo) are FDA-approved, meaning they have been independently evaluated for safety, effectiveness, and manufacturing quality. Compounded GLP-1 medications are prepared by compounding pharmacies and are not FDA-approved as finished products. Quality depends on the specific compounding pharmacy. Brand-name carries less regulatory risk; compounded costs less.

Eden, MEDVi, NovoCare, and LillyDirect Foundayo all operate without a separate membership or platform fee. Your payment covers the medication and, for Eden and MEDVi, the telehealth consultation. GoodRx, Ro, Mochi, and Hims all charge a separate membership.

NovoCare and LillyDirect are fill-by-fill with no subscription — you simply don't refill. Among telehealth options, Mochi and GoodRx have the simplest cancellation. Ro has the strictest policy — the membership auto-renews, must be canceled at least 48 hours before the next renewal date, and is non-refundable once the billing cycle begins.

Yes. LillyDirect Foundayo (orforglipron) and NovoCare Wegovy pill (oral semaglutide) are both FDA-approved daily pills available to cash-pay patients. Foundayo starts at $149/mo. The Wegovy pill starts at $149/mo for lower doses. Both launched in 2026.

GLP-1 medications prescribed by a licensed physician are generally eligible as HSA/FSA medical expenses, reducing your effective cost by 20–35% depending on your tax bracket. Mochi, MEDVi, and Eden explicitly market HSA/FSA acceptance. For other programs, confirm HSA/FSA eligibility during enrollment.

No. GoodRx Care Direct excludes Alabama and Louisiana. Hims & Hers says GLP-1s are not available in all states. Mochi and Eden both state availability in all 50 states for compounded options. Manufacturer-direct programs (NovoCare, LillyDirect) are available wherever a licensed prescriber can write the prescription.

Programs use introductory pricing to reduce the barrier to starting treatment. NovoCare's Wegovy pen goes from $199 (first two fills) to $349. MEDVi goes from $179 to $299. GoodRx's Wegovy pen goes from $199 to $349. The jump happens because the intro price is subsidized by a manufacturer partnership, a first-month discount, or is limited to the lowest non-maintenance doses.

Check for: (1) LegitScript certification, (2) named, licensed compounding pharmacy partners, (3) state medical licenses for prescribers, (4) clear disclaimers that compounded medications are not FDA-approved, (5) transparent pricing that matches what you pay at checkout, and (6) a cancellation policy you can find before signing up.

Still not sure which GLP-1 cash-pay program is right for you?

Take our free 60-second matching quiz — we'll ask about your budget, medication preference, state, and insurance situation, then show you the 2–3 programs that fit. No email required to see results.

Ready to compare specific programs?

Affiliate Disclosure: Some links on this page are affiliate links. If you enroll through our links, we may earn a commission at no extra cost to you. This does not affect our rankings, pricing data, or our decision to include non-affiliate programs like NovoCare, LillyDirect, GoodRx, and Mochi. We have declined to feature providers that did not meet our verification standards, including some that offered partnerships. Full editorial policy available on our About page.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that require evaluation by a licensed healthcare provider. Compounded medications are not FDA-approved as finished products. Always consult a qualified healthcare professional before starting any weight-loss treatment.

Last full verification: April 8, 2026.

Related Articles